IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SPOSITO, CARLO FERRUCCIO ALVISE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.549
NA - Nord America 2.234
AS - Asia 1.206
SA - Sud America 90
OC - Oceania 35
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.133
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.114
DE - Germania 1.854
GB - Regno Unito 1.025
IT - Italia 682
CN - Cina 665
SE - Svezia 286
IN - India 145
IE - Irlanda 140
FR - Francia 137
CA - Canada 109
ES - Italia 85
KR - Corea 79
HK - Hong Kong 69
TR - Turchia 62
DK - Danimarca 50
FI - Finlandia 50
JP - Giappone 45
AR - Argentina 44
UA - Ucraina 42
BE - Belgio 39
BR - Brasile 35
SG - Singapore 35
AU - Australia 31
VN - Vietnam 27
PT - Portogallo 24
NL - Olanda 23
RU - Federazione Russa 19
GR - Grecia 18
CH - Svizzera 16
TH - Thailandia 13
PH - Filippine 12
TW - Taiwan 11
ID - Indonesia 9
IR - Iran 9
MX - Messico 9
AT - Austria 8
BY - Bielorussia 7
CO - Colombia 7
EU - Europa 7
NO - Norvegia 7
PL - Polonia 7
EG - Egitto 6
MY - Malesia 5
SC - Seychelles 5
BD - Bangladesh 4
CL - Cile 4
EE - Estonia 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
IL - Israele 3
RO - Romania 3
TN - Tunisia 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
HR - Croazia 2
HU - Ungheria 2
LT - Lituania 2
MK - Macedonia 2
MM - Myanmar 2
NP - Nepal 2
UG - Uganda 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
GH - Ghana 1
GT - Guatemala 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
PR - Porto Rico 1
Totale 8.140
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.658
Southend 946
Chandler 318
Milan 249
Princeton 141
Dublin 135
Seattle 124
Wilmington 120
Houston 105
Ann Arbor 99
Fairfield 98
Beijing 84
Redwood City 79
Dearborn 78
Ashburn 71
Toronto 60
Woodbridge 57
Des Moines 51
Nanjing 47
Rome 45
Shanghai 44
Bengaluru 42
Phoenix 37
Ottawa 35
Buenos Aires 34
Jinan 34
New York 33
Cambridge 32
Guangzhou 32
Hangzhou 29
Seoul 28
Boardman 24
Berlin 23
Helsinki 22
London 22
Brussels 21
Central 20
Madrid 19
Fremont 18
Paris 18
Dong Ket 17
Hong Kong 17
Nanchang 17
Bologna 16
Duncan 16
Grafing 16
Jacksonville 16
Shenyang 16
Changsha 15
Hebei 15
Andover 14
Chicago 14
Fuzhou 14
Tianjin 14
Istanbul 13
Tokyo 13
Wuhan 13
Athens 12
Bühl 11
Central District 11
Delhi 11
Hamburg 11
Jiaxing 11
São Paulo 11
Zhengzhou 11
Lanzhou 10
Mountain View 10
Redmond 10
San Francisco 10
Serra 10
Falls Church 9
Los Angeles 9
Melbourne 9
Valencia 9
San Diego 8
Badajoz 7
Bangkok 7
Chengdu 7
Florence 7
Hefei 7
Munich 7
Ningbo 7
Shenzhen 7
Singapore 7
Somerville 7
Zurich 7
Bogotá 6
Carugate 6
Chongqing 6
Essen 6
Haikou 6
Kiel 6
Malatya 6
Marcallo con Casone 6
Matosinhos Municipality 6
Mumbai 6
Sakarya 6
Silver Spring 6
Albany 5
Barcelona 5
Totale 5.730
Salva come PNG Salva come JPEG
Nome #
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 1.102
Transplantation of autologous extracellular vesicles for cancer-specific targeting 244
Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava 213
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant 211
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study 185
Development of a prognostic scoring system for resectable hepatocellular carcinoma 174
Bowel ultrasound follow-up of Crohn disease after surgery allows the early identification of those patients at high risk of clinical or surgical recurrence 167
Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors 161
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients 159
Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal 155
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 142
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 140
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 138
Serial US measurement of bowel wall thickness after conservative surgery is highly predictive of clinical or surgical recurrence in patients with Crohn's disease 135
Behaviour of the bowel wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn's disease : a prospective study 134
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma 132
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 121
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis 109
Serial ultrasound measurement of bowel wall thickness after conservative surgery is highly predictive of clinical or surgical recurrence in patients with Crohn's disease 106
Portal vein arterialization for hepatic artery thrombosis in liver transplantation : a case report, Doppler-ultrasound aspects, and review of the literature 106
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 105
Hepatocellular Carcinoma in Abernethy Malformation: A Rare Occurrence of Congenital Complete Portosystemic Shunt 103
Indocyanine Green Fluorescence-Guided Surgery for Gastrointestinal Tumors: A Systematic Review 101
Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients. 101
The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors 100
A Combined Approach to Priorities of Surgical Oncology During the COVID-19 Epidemic 99
Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma : a phase II study 98
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma 96
Tremelimumab and durvalumab combination for the non-operative management (NOM) of microsatellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer : The multicentre, single-arm, multi-cohort, phase II INFINITY study 96
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis 94
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 91
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma 91
Repeated transarterial chemoembolization : an overfitting effort? 91
Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads 87
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL) : a randomised, controlled, phase 2b/3 trial 86
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation : a proof of principle 85
Intrahepatic Flow Redistribution in Patients Treated with Radioembolization 84
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience 83
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study 82
Strictureplasty in the surgical treatment of complicated Crohn's disease 78
Resection of hepatocellular cancer ≤2 cm: results from two Western centers 77
Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma 77
Radioembolization of hepatocarcinoma with 90Y glass microspheres : development of an individualized treatment planning strategy based on dosimetry and radiobiology 76
Long-term outcome of patients undergoing resection versus transplantation for neuroendocrine liver metastases meeting the Milan Criteria 73
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma 73
Improved management of grade B biliary leaks after complex liver resections using gadoxetic acid disodium–enhanced magnetic resonance cholangiography 73
Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads: Clinical–Radiological Outcomes and Safety Profile 72
Hierarchic interaction of factors associated with liver decompensation after resection for hepatocellular carcinoma 72
ASO Visual Abstract: Impact of Surgical Margins on Overall Survival After Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series 72
Preoperative predictors of liver decompensation after mini-invasive liver resection 71
The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients : reasons for a failure, and perspectives for the future 70
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study 70
Reply to: Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma 69
Correction to: Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 69
External validation of an individual prognostic calculator after transarterial chemoembolization for hepatocellular carcinoma 67
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres : the experience of the National Tumor Institute of Milan 66
Reply to : sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue 64
The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors : Pros and cons 64
Reply to: Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 63
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma 62
Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment 62
Pro (With Caution): Extended oncologic indications in liver transplantation 62
Reply to: Letter regarding 'Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma' 62
Effect of age on survival in patients undergoing resection of hepatocellular carcinoma 60
Reply 59
Liver resection for perihilar cholangiocarcinoma :Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study 58
The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review 56
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 56
Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma 54
Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma 54
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial) 53
Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series 51
Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation 47
ASO Author Reflections: Less is more: Organ-Sparing Approach for the Surgical Treatment of Gastric Adenocarcinoma 46
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients with Metabolic Syndrome 44
Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma 44
Relative Survival Instead of Overall Survival Should Be Used as Outcome When Analyzing the Effect of Age After Treatment of Hepatocellular Carcinoma 44
ASO Visual Abstract: Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative Phase 2 Clinical Trial 43
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with90Y glass microspheres 41
Innate immunity in colorectal liver metastases: macrophage morphology and distribution are strong predictors of prognosis: An external validation 38
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study 38
Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative, Phase 2, Clinical Trial 36
Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues 35
Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma 35
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors 33
ASO Author Reflections: A Green Eye on Lymphadenectomy for Gastric Cancer 31
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome 29
Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective 29
Transhepatic anterior approach to the inferior vena cava in large retroperitoneal tumors resected en bloc with the right liver lobe 19
Totale 8.604
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201960 0 0 0 0 0 0 0 0 0 0 34 26
2019/20201.042 94 26 21 108 77 166 113 47 141 150 53 46
2020/2021998 66 91 81 30 85 104 71 93 130 81 73 93
2021/20221.164 61 56 43 101 90 79 60 60 167 121 76 250
2022/20231.480 148 131 98 168 161 235 74 88 173 29 112 63
2023/20242.572 54 74 138 96 182 144 576 506 254 473 75 0
Totale 8.604